Techno Drugs Ltd. (DSE:TECHNODRUG)
Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
29.50
+0.40 (1.37%)
At close: Jan 1, 2026

Techno Drugs Income Statement

Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '25 Jun '25 Jun '24 Jun '23 Jun '22
3,2333,3763,6132,7335,029
Revenue Growth (YoY)
1.80%-6.58%32.19%-45.64%-
Cost of Revenue
1,8371,9192,0981,5793,224
Gross Profit
1,3961,4571,5151,1541,804
Selling, General & Admin
707.72758.69848.23628.04905.09
Operating Expenses
707.72758.69848.23628.04905.09
Operating Income
688.44698.33666.8526899.4
Interest Expense
-419.14-411.48-305.93-263.87-256.61
Interest & Investment Income
1.851.852.552.6211.97
Currency Exchange Gain (Loss)
---0.19-0.01-
Other Non Operating Income (Expenses)
-1.93-1.86-3.64-5.69-3.74
Pretax Income
269.21286.83359.59259.05651.02
Income Tax Expense
53.5754.8178.9963.55171.24
Net Income
215.64232.02280.6195.51479.78
Net Income to Common
215.64232.02280.6195.51479.78
Net Income Growth
-15.64%-17.31%43.53%-59.25%-
Shares Outstanding (Basic)
134132959494
Shares Outstanding (Diluted)
134132959494
Shares Change (YoY)
30.38%38.07%1.34%--
EPS (Basic)
1.611.762.942.085.10
EPS (Diluted)
1.611.762.942.085.10
EPS Growth
-35.30%-40.11%41.62%-59.25%-
Free Cash Flow
-569.41-479.5283.64-416.28-1.52
Free Cash Flow Per Share
-4.25-3.640.88-4.42-0.02
Dividend Per Share
1.0001.0001.200--
Dividend Growth
-16.67%-16.67%---
Gross Margin
43.18%43.16%41.93%42.22%35.88%
Operating Margin
21.29%20.69%18.45%19.24%17.89%
Profit Margin
6.67%6.87%7.77%7.15%9.54%
Free Cash Flow Margin
-17.61%-14.21%2.31%-15.23%-0.03%
EBITDA
-1,053990.74817.361,151
EBITDA Margin
-31.19%27.42%29.90%22.89%
D&A For EBITDA
-354.38323.94291.35251.54
EBIT
688.44698.33666.8526899.4
EBIT Margin
21.29%20.69%18.45%19.24%17.89%
Effective Tax Rate
19.90%19.11%21.97%24.53%26.30%
Advertising Expenses
-1.370.760.260.59
Source: S&P Global Market Intelligence. Standard template. Financial Sources.